We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$73.1B
AUM Growth
+$2.4B
Cap. Flow
-$1.43B
Cap. Flow %
-1.96%
Top 10 Hldgs %
11.25%
Holding
4,601
New
626
Increased
1,390
Reduced
2,018
Closed
524

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$839M
2
AMZN icon
Amazon
AMZN
+$810M
3
TSLA icon
Tesla
TSLA
+$644M
4
TSM icon
TSMC
TSM
+$546M
5
JNJ icon
Johnson & Johnson
JNJ
+$389M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$891M
2
HD icon
Home Depot
HD
+$441M
3
JPM icon
JPMorgan Chase
JPM
+$335M
4
NVO
Novo Nordisk
NVO
+$317M
5
ASML icon
ASML
ASML
+$315M

Sector Composition

Rank Sector Weight
1 Healthcare 20.81%
2 Technology 15.51%
3 Consumer Discretionary 11.84%
4 Consumer Staples 10.09%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BR icon
4126
Broadridge
BR
$18.4B
-140,500
Closed -$20.3M
BRKR icon
4127
Bruker
BRKR
$9.4B
-273,510
Closed -$14.5M
BTAI icon
4128
BioXcel Therapeutics
BTAI
$24.8M
-2,219
Closed -$420K
BULZ icon
4129
MicroSectors FANG & Innovation 3x Leveraged ETN
BULZ
$209M
-388,100
Closed -$1.01M
BURL icon
4130
Burlington
BURL
$23.4B
-217,900
Closed -$24.4M
BYSI icon
4131
BeyondSpring
BYSI
$47.3M
-170,996
Closed -$169K
CAKE icon
4132
Cheesecake Factory
CAKE
$5.03B
-34,045
Closed -$997K
CASH icon
4133
Pathward Financial
CASH
$1.88B
-21,900
Closed -$722K
CDLX icon
4134
Cardlytics
CDLX
$22.2M
-22,774
Closed -$2.14M
CELH icon
4135
Celsius Holdings
CELH
$7.38B
-438,900
Closed -$13.3M
CGGR icon
4136
Capital Group Growth ETF
CGGR
$23.2B
-56,600
Closed -$1.1M
CHDN icon
4137
Churchill Downs
CHDN
$6.17B
-157,250
Closed -$14.5M
CHRS icon
4138
Coherus Oncology
CHRS
$217M
-52,800
Closed -$507K
CHTR icon
4139
Charter Communications
CHTR
$17.3B
-48,900
Closed -$14.8M
CHWY icon
4140
Chewy
CHWY
$9.54B
-11,400
Closed -$350K
CKPT
4141
DELISTED
Checkpoint Therapeutics
CKPT
-35,750
Closed -$372K
CLDX icon
4142
Celldex Therapeutics
CLDX
$2.94B
-25,888
Closed -$728K
CMCSA icon
4143
Comcast
CMCSA
$87.3B
-6,211,676
Closed -$182M
CNSP icon
4144
CNS Pharmaceuticals
CNSP
$7.31M
0
-$10K
COGT icon
4145
Cogent Biosciences
COGT
$6.76B
-15,168
Closed -$226K
COHR icon
4146
Coherent
COHR
$43.4B
-8,000
Closed -$279K
COLM icon
4147
Columbia Sportswear
COLM
$3.25B
-26,300
Closed -$1.77M
COPX icon
4148
Global X Copper Miners ETF NEW
COPX
$7.04B
-23,100
Closed -$653K
CPAC
4149
Cementos Pacasmayo
CPAC
$1.04B
-10,133
Closed -$47K
CQQQ icon
4150
Invesco China Technology ETF
CQQQ
$3.01B
-9,500
Closed -$345K

Similar funds

Renaissance Technologies's Q4 2022 Portfolio in Review

As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
  • Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
  • Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
  • Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
  • Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
  • Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.